Author:
Kelleher Dennis,Tombs Lee,Preece Andrew,Brealey Noushin,Mehta Rashmi
Subject
Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine
Reference35 articles.
1. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience;De Ponti;Eur J Clin Pharmacol,2000
2. Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period;Raschi;Br J Clin Pharmacol,2009
3. Can pharmacogenetics help rescue drugs withdrawn from the market?;Shah;Pharmacogenomics,2006
4. ICH Topic E14. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs;European Medicines Agency,2005
5. Guidance for industry. E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs;US Department of Health and Human Services Food and Drug Administration,2005
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献